The present danger of New Delhi metallo-β-lactamase: a threat to public health

Usman Qamar, Muhammad, S Lopes, Bruno, Hassan, Brekhna, Khurshid, Mohsin, Shafique, Muhammad, Atif Nisar, Muhammad, Mohsin, Mashkoor, Nawaz, Zeeshan, Muzammil, Saima, Aslam, Bilal, Ejaz, Hasan and Toleman, Mark A. ORCID: https://orcid.org/0000-0002-9497-0512 2020. The present danger of New Delhi metallo-β-lactamase: a threat to public health. Future Microbiology 15 (18) , pp. 1759-1778. 10.2217/fmb-2020-0069

Full text not available from this repository.

Abstract

The evolution of antimicrobial-resistant Gram-negative pathogens is a substantial menace to public health sectors, notably in developing countries because of the scarcity of healthcare facilities. New Delhi metallo-β-lactamase (NDM) is a potent β-lactam enzyme able to hydrolyze several available antibiotics. NDM was identified from the clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Swedish patient in New Delhi, India. This enzyme horizontally passed on to various Gram-negative bacteria developing resistance against a variety of antibiotics which cause treatment crucial. These bacteria increase fatality rates and play an integral role in the economic burden. The efficient management of NDM-producing isolates requires the coordination between each healthcare setting in a region. In this review, we present the prevalence of NDM in children, fatality and the economic burden of resistant bacteria, the clonal spread of NDM harboring bacteria and modern techniques for the detection of NDM producing pathogens.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Future Science Group
ISSN:	1746-0913
Date of First Compliant Deposit:	18 November 2021
Date of Acceptance:	19 November 2020
Last Modified:	14 Mar 2024 02:07
URI:	https://orca.cardiff.ac.uk/id/eprint/145594

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item